Novartis AG (BVMF:N1VS34)

Market Cap	1.37T
Revenue (ttm)	300.43B
Net Income (ttm)	76.71B
Shares Out	n/a
EPS (ttm)	38.90
PE Ratio	17.80
Forward PE	15.49
Dividend	1.42 (2.03%)
Ex-Dividend Date	Mar 11, 2025

Volume	9
Average Volume	134
Open	70.77
Previous Close	69.02
Day's Range	70.77 - 70.77
52-Week Range	58.53 - 72.00
Beta	0.44
RSI	51.18
Earnings Date	Feb 4, 2026

About Novartis AG

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocy...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1996
• Employees: 75,883
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: N1VS34

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.

Financial numbers in USD